On behalf of the Swiss Federal Office of Public Health (FOPH), INFRAS, together with Prof. Dr. Nicole Probst-Hensch from the Swiss Tropical and Public Health Institute, has examined the consequences of the preliminary draft law of cancer registration. The aim of the draft law is to standardise the data collection and to uniform the regulations regarding data handling. The Swiss government will play a key role in this process by running a central national cancer registry. A great part of the assigned tasks are already being carried out by the sub-national i.e. cantonal registries as well as the Swiss Childhood Cancer Registry (SCCR) and the National Institute for Cancer Epidemiology and Registration (NICER). The Swiss government expects additional costs of CHF 1,4 to 1,6 million, while the costs of approx. CHF 1 million is used for financial support in order to develop and promote the registration of other diseases. The anticipated extra costs for the cancer registration are therefore manageable. Furthermore, the cancer registration generates a substantial benefit for health care, health policy and research. With little time expenditure, the law allows a high added value to be reached.

Regulatory consequences of cancer registration

Project team

Duration

Topics

Who we work for

Downloads

Contacts